Physician profile
David E Mangold
NPI 1588678726
$8,924.55
in general payments reported to CMS, 2019-2025
25 companies · $2,015 in 2025
The $2,015 reported for 2025 was more than what 82% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,224 · 2020: $356 · 2021: $251 · 2022: $596 · 2023: $1,912 · 2024: $1,572 · 2025: $2,015.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,511 · Food and Beverage: $1,978 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,510.94 |
| Food and Beverage | $1,978.25 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,292.68 | 2019-2025 | Da Vinci Surgical System |
| W. L. Gore & Associates, INC. | $2,792.45 | 2019-2023 | Gore Bio-A Tissue Reinforcement, Seamguard |
| Stryker Corporation | $134.44 | 2024-2025 | 1788, Spy-Phi System, Molli |
| Coopersurgical, INC. | $127.43 | 2022-2024 | Advincula Delineator Uterine Manipulator, Supercut Hysterectomy Scissors |
| Conmed Corporation | $81.64 | 2021 | |
| Ethicon US, LLC | $65.73 | 2019 | |
| Endomagnetics Ltd | $64.47 | 2021-2024 | Magtrace, Magseed |
| Genentech USA, INC. | $40.95 | 2019 | |
| Profound Medical Corp. | $34.39 | 2023 | Tulsa-Pro |
| Innovation Technologies INC | $23.97 | 2023 | Irrisept |
| Astrazeneca Pharmaceuticals Lp | $22.74 | 2019 | |
| Baxter Healthcare | $22.48 | 2023 | Tisseel |
| Medtronic, INC. | $22.16 | 2025 | Ligasure |
| Amgen INC. | $22.08 | 2019 | |
| Integra Lifesciences Corporation | $20.07 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $19.72 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $18.07 | 2019 | |
| Emd Serono, INC. | $17.64 | 2020 | |
| Tactile Systems Technology INC | $17.29 | 2023 | Flexitouch Plus, Entre Plus |
| Biocomposites INC | $17.25 | 2025 | Stimulan |
| Elucent Medical | $14.65 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $13.56 | 2025 | Dupixent |
| Janssen Biotech, INC. | $13.27 | 2020 | |
| Boston Scientific Corporation | $13.19 | 2023 | Spyscope Ds |
| Eisai INC. | $12.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Mangold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.